Boston Scientific announces 2027 COO transition and three segments
Published on 10/17/2026 at 10:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSLeadership structure takes shape
- Boston Scientific announced Joseph M. Fitzgerald as chief operating officer on October 7, 2026.
- Fitzgerald is scheduled to assume the role on January 1, 2027.
- Three reportable segments are scheduled to be established on January 1, 2027.
Boston Scientific Corporation announced on October 7, 2026, that Joseph M. Fitzgerald will become executive vice president and chief operating officer effective January 1, 2027. The company said Fitzgerald will oversee its global operations, business units and regions. The announcement was published by Boston Scientific Corporation.
Boston Scientific said it will establish three reportable segments effective January 1, 2027: Interventional Therapies, Rhythm Solutions and MedSurg. The company said the new operating model is intended to support faster decision-making and the allocation of investments across its portfolio.
Weekend trading and company dates
Boston Scientific Corporation is listed on the New York Stock Exchange under the ticker BSX, according to its October 7 announcement. The next stated organizational date is January 1, 2027, when the leadership change and the three-segment structure are scheduled to take effect.
Market context: Market report S&P 500.
The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Boston Scientific stock.
